Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Scandinavian ChemoTech signs agreement with AIIMS Jodhpur, to establish a Centre of Excellence (CoE) as part of the India Sweden Healthcare Innovation Centre

After a solid process, which was delayed by the pandemic, ChemoTech has now reached a long-awaited milestone by establishing a Centre of Excellence "CoE" at the India Sweden Healthcare Innovation Centre. This Innovation Centre is physically located at the All India Institute of Medical Sciences (AIIMS) Jodhpur and is part of the state cooperation in health care between Sweden and India and is an initiative that is co-financed by the Swedish and Indian states.This agreement means that AIIMS Jodhpur and ChemoTech, through this CoE, will conduct clinical studies with the aim of creating

Nomination committee appointed ahead of 2022 Annual General Meeting of Pricer AB

In accordance with the decision at the Annual General Meeting on April 29, 2021 Pricer’s Chairman of the Board Knut Faremo has contacted the company’s three largest shareholders to form a Nomination Committee. Shareholders shall also include such a group of two or more shareholders who have notified the Chairman of the Board that they wish to participate jointly in the Nomination Committee's work.   The shareholders and representatives comprising the Nomination Committee are: – Göran Sundholm, own holding.  – Ulf Palm, nominated by Sifonen AB/Lars Ingvarsson, Hans Granberg,

Interim Report January – September 2021

· Net revenue from property management was SEK 1,339 million (1,281), an increase of 5 per cent. Elimination of intra-Group rent revenue amounted to SEK 109 million (33), attributable primarily to NK Retail. · Gross profit from property management increased by 4 per cent, totalling SEK 932 million (897), which is attributable primarily to higher rent revenue. Elimination of intra-Group rent revenue amounted to SEK 109 million (33). · Net profit for the period after tax was SEK 1,271 million (-1,003), equivalent to SEK 6.28 per share (-4.87). The increase is attributable to

Polymer Factory Sweden AB extends quality agreement with Merck KGaA

Polymer Factory has extended its Quality Agreement with re-seller Merck KGaA, to include more of Polymer Factory’s SpheriCal® products. This is an addition to the existing agreement between the parties.In order for Merck to re-sell Polymer Factory SpheriCal® products, a Quality Agreement exists between the parties covering the distributed products. The extension of the agreement means that Merck can now repurchase more of Polymer Factory SpheriCal® products. Several of the products are currently available for purchase at Merck. The relationship with re-sellers and distributors means that

Trevian wins contract to develop a landmark building in the expanding Helsinki city centre

Trevian Asset Management has recently entered into a comprehensive real estate asset management agreement with Suomen Kuntasäätiö (The Finnish Municipal Foundation) to develop the 18 000 sqm Kallio Kuntatalo (The Kallio Municipal House) in Helsinki. Helsinki's core districts, such as Kallio, are key development areas whose attractiveness has been promoted, for example, through extensive construction projects and town plan changes. Moreover, these new areas of modern urban culture have already become the most popular residential areas in Helsinki.Helsinki city centre has expanded to nearby

Embrace The Afterlife With the Necroids Species Pack, Available Now For Stellaris: Console Edition

Stellaris’ Most Popular Species Pack Wraps Up Expansion Bundle FourSTOCKHOLM - Nov 11, 2021 - Paradox Interactive, a publisher and developer of games that are scientifically proven to haunt your gaming setup, has announced that the Necroids Species Pack is available now for Stellaris: Console Edition on Xbox and Playstation consoles for $7.99 / £5.79 / €7.99 MSRP. This expansion marks the final chapter of Stellaris: Console Edition’s fourth expansion pass, which also includes the Ancient Relics Story Pack and the Federations full expansion. Grab the last pieces of your halloween candy

Nordea Bank Abp: Flagging notification in accordance with Chapter 9, Section 10 of the Securities Markets Act

Nordea Bank AbpStock exchange release – Major shareholder announcements11 November 2021 at 12.00 EET Nordea Bank Abp has on 10 November 2021 received a notification under Chapter 9, Section 5 of the Securities Markets Act, according to which BlackRock, Inc.'s indirect shareholding of Nordea Bank Abp’s shares and voting rights has decreased below the threshold of 5 per cent on 9 November 2021. The total number of shares and voting rights in Nordea Bank Abp is 4,007,348,931. Total positions of BlackRock, Inc. and its funds according to the notification: +----------------+------

Episurf Medical to present at Redeye Life Science Day today, November 11[th], 2021

Episurf Medical (Nasdaq: EPIS B) will attend Redeye Life Science Day which is held today, November 11th, 2021. The event is arranged by Redeye and the company will be represented by its founder Prof. Leif Ryd. The presentation will be streamed live at 15:40 CET at https://www.redeye.se/events/815899/redeye-life-science-day-2021 and will also be made available afterwards on our website www.episurf.com.

Risk calculator to prevent delayed discharges in hospitals

New research could significantly reduce overcrowding in emergency departments – potentially saving the NHS millions of pounds.In a collaborative project between University Hospitals of North Midlands (UHNM) NHS Trust and Staffordshire University, experts have developed a prediction model to identify patients most at risk of taking up hospital beds longer than needed. A new study, funded by the North Staffordshire Medical Institute (NSMI), led by the core team of Dr Andrew Davy (UHNM) with Associate Professor Md Assaduzzaman (Staffordshire University) and Mr Thomas Hill (UHNM) details an

Aspire Global’s Pariplay continues expansion in the US with BetMGM deal

Aspire Global’s  Pariplay, the leading aggregator and content provider, has signed a distribution deal with BetMGM, the leading online casino operator in the US. This agreement will enable Pariplay to offer its proprietary games and aggregated third-party content to BetMGM’s players in New Jersey and Michigan, with the potential to expand into other live markets in the future.Through partnering with BetMGM, Pariplay is taking a strategically important step toward the long-term goal of becoming a leading content supplier in North America, where it has recently

Europa Universalis IV Origins Immersion Pack Now Available

New Pack Adds Greater Variety and Depth for African Nations11 November 2021 - STOCKHOLM - From the trading ports on the eastern coast to the gold mines of Mali, early modern Africa was a continent of rich kingdoms and cultural variety. Now, Europa Universalis IV: Origins brings this history to vivid life with new missions, events and regional flavor. This immersion pack is available for the suggested retail price of $9.99/￡7.19/€9.99. See the trailer here: https://youtu.be/aKDHIhE0VlE Europa Universalis IV: Origins includes: · Jewish Religion: The Ethiopian Jews of Beta Israel

Employee well-being at the core of people-focused hybrid work

The report “Leading hybrid work: Five lessons for executives” commissioned by YIT underlines employee well-being, humanity and hybrid work strategy as significant leadership guidelines.How to lead people when knowledge work is done partly at the office and partly from home? How to harness the ways of action, premises and technologies to support employee well-being and, at the same time, enable efficient business?In cooperation with The NextGen Project and Microsoft, we have compiled a report called “Leading hybrid work: Five lessons for executives”, which was supplemented with the

Invitation to presentation of Nanoform’s Q3/2021 report on November 25, 2021

Press release Nanoform Finland Plc November 11, 2021 11:00 a.m. Finnish time / 10:00 a.m. Swedish time Invitation to presentation of Nanoform’s Q3/2021 report on November 25, 2021 Helsinki, Finland – Nanoform Finland Plc (“Nanoform”), an innovative nanoparticle medicine enabling company, will publish its Q3/2021 report on November 25, 2021, at 8.10 a.m. Finnish time / 7.10 a.m. Swedish time. The company will hold a conference call and an online presentation on the same day at 3.00 p.m. Finnish time / 2.00 p.m. Swedish time. Nanoform will be represented by CEO Edward

Correction: Eevia Health’s Board of Directors has resolved, subject to approval at an Extraordinary General Meeting, on a directed share issue of SEK 20 million

This is a correction to press release published 10 November, 2021 where the press release lacked a reference to the EU´s Market Abuse Regulation (MAR). The Board of Directors of Eevia Health Plc (publ) (“Eevia” or the “Company”) has resolved, subject to the approval by shareholders at an Extraordinary General Meeting (the “EGM”), on a directed new issue of 2,061,856 shares at a subscription price of SEK 9.70 per share (the “Directed Share Issue”), which is expected to raise proceeds to the Company of SEK 20 million before issue costs. The proceeds will primarily be used for investments in

NOTIFICATION OF MANAGERS’ AND CLOSELY RELATED PARTIES’ TRANSACTIONS WITH DAMPSKIBSSELSKABET NORDEN A/S’ SHARES IN CONNECTION WITH SHARE BUY-BACK PROGRAM

ANNOUNCEMENT NO. 84 - 11 NOVEMBER 2021 In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, A/S Motortramp participates by selling shares pro rata in order to maintain the current ownership of just under 32% of the shares in Dampskibsselskabet NORDEN A/S. The market will be informed accordingly – see the attached file and announcement no. 75/2021. Kind regards, Dampskibsselskabet NORDEN A/S Martin Badsted CFO For further information:Thomas France, Investor Communications Partner, tlf.: 3315 0451

Tomi Saine appointed Mill Manager of Metsä Fibre's Vilppula sawmill

Metsä Fibre press release 11.11.2021Tomi Saine has been appointed Mill Manager of Metsä Fibre's Vilppula sawmill and will start in his new position on 1 January 2022. Saine currently works as District Manager of Metsä Forest's Seinäjoki sourcing district. As Sawmill Manager, Saine reports to Jari Tikkanen, SVP of Metsä Fibre's Sawmill Business Jaakko Vierola, the former Mill Manager at Vilppula sawmill, has moved to Rauma sawmill project as Technical Director in October.

“Someone has to be first” – Kiilto offers game-changing, green adhesive innovations for the packaging industry

Kiilto is a chemical industry pioneer that has its gaze firmly fixed on the future – on a sustainable future, to be exact. The road to a greener tomorrow is paved with new innovations, such as the world's first biodegradable hot melt adhesive.Kiilto, a 100-year-old family business offers chemical industry solutions in four business areas: Industrial Adhesives and Fireproofing, Construction, Professional Hygiene and Consumer Goods. “Among the things we are known for are our top-quality adhesive solutions. In this business area, our customer base includes companies from the packaging and

World War II drama ‘Gold Run’ is Viaplay’s first Norwegian original film

· Feature-length film stars Jon Øigarden (‘Exit’), Sven Nordin (‘Wisting’) and Axel Bøyum (‘Delete Me’) · ‘Gold Run’ is the first Viaplay Original film from Norway · Viaplay to premiere at least 60 Originals in 2022 The first-ever Norwegian Viaplay Original film will be the World War II drama ‘Gold Run’, based on the extraordinary true story of a group of unlikely resistance fighters who smuggled Norway’s gold reserves out of the country ahead of invading Nazi forces. Jon Øigarden (‘Exit’), Sven Nordin (‘Wisting’) and Axel Bøyum (‘Delete Me’) lead an all-star Norwegian cast in the

Reminder - Invitation to Pexip Q3 2021 Results Presentation

Pexip will present its third quarter results for 2021 today, 11 November, at 17:00 CET. The report and presentation will be made available at 16:30 CET at investor.pexip.com and newsweb.no.Pexip will host a physical presentation at Felix Konferansesenter (Atlantic), Bryggetorget 3, Oslo, Norway. For registration, please follow this link and select either in-person presentation in Oslo or webcast: https://www.pexip.com/q3-2021-results-presentation-registration A live webcast of the event will also be streamed via https://channel.royalcast.com/landingpage/hegnarmedia/20211111_17/

Elkem Silicones will present silicone solutions for additive manufacturing/3D printing at formnext 2021 in Frankfurt.

Elkem Silicones will be present at the upcoming Formnext show, the leading industry platform for additive manufacturing and industrial 3D printing in Frankfurt in Germany from November, 16[th] to 19[th] and will showcase its wide portfolio of silicone solutions for Additive Manufacturing/3D Printin.To answer the challenging megatrends, Elkem Silicones has created a brand-new technology, called AMSil™ & AMSil SILBIONE™ series, to make functional parts based on genuine silicone elastomers by Additive Manufacturing/3D Printing. • AMSil™ 20000 series for use in industrial applications (

BioStock studio: Saniona celebrates a decade of progress

Today marks Saniona’s 10th anniversary since its founding. BioStock was visited in the studio by the company’s founder Jørgen Drejer, now Chief Scientific Officer, who talks about the transformation that the company has undergone during this decade. We also learn more about the success of the primary drug candidate Tesomet, the importance of now having a US-based management team and his view of the company’s future.Watch the interview with Jørgen Drejer at biostock.se : https://www.biostock.se/en/2021/11/biostock-studio-saniona-celebrates-a-decade-of-progress/

BioStock: SynAct Pharma’s CSO and CMO comment on clinical development

SynAct Pharma continues to make progress in the development of the anti-inflammatory drug candidate AP1189. The company recently announced that AP1189 can be dosed for three months in future clinical studies, supported by preclinical toxicology results. Also, SynAct has now formulated AP1189 as a tablet – which is another big step for future clinical development. By the end of November, SynAct Pharma expects to present key results from BEGIN, a clinical phase IIa study in the primary indication rheumatoid arthritis. BioStock reached out to the company’s CSO Thomas Jonassen and CMO Anders Dyhr

Comment on reported PDMR transaction by BGA Invest

Minesto's largest owner, BGA Invest AB, has today reported a sale of shares in Minesto AB to the Swedish financial supervisory authority’s PDMR* transactions register. BGA Invest remains the largest owner, and an active and long-term owner, in Minesto.BGA Invest AB has reported that the company has sold 1,500,000 shares, corresponding to approximately 4.8 percent of BGA Invest's holding in Minesto. The buyer of the shares is a European financial fund. After the transaction, BGA Invest remains the largest owner in Minesto with a holding of 29,800,840 shares, which corresponds to

There are no items matching the current filter
There are no more items matching the current filter
Back to top